Some of the material created during the STARDUST project will be published on this page, such as flyers and other communication materials, as well as deliverables with dissemination level ‘public’.

Communication material

Flyer version 1 / version 2


Aarhus University

  • A. Rashidi et al. 2019. An Ultrasonically Powered Optogenetic Microstimulators with Power-Efficient Active Rectifier and Charge Reuse Capability. 2019 IEEE International Symposium on Circuits and Systems (ISCAS). www / pdf


  • A-M. Ouagazzal et al. 2019. Effects of External Globus Pallidus Photostimulation on Motor Behavior in Normal and Hemi-Parkinson Mice. Poster abstract at IBAGS 2019. www / pdf

  • S. Ztaou et al. 2019. Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease. Neurochemistry International. Vol 126:1-10. www

  • S. Ztaou et al. 2018. Striatal cholinergic interneurons regulate cognitive and affective dysfunction in partially dopamine-depleted mice. European Journal of Neuroscience. Vol 48 (9). www / pdf

Humboldt University

  • Y. A. Bernal-Sierra et al. 2018. Potassium channel-based optogenetic silencing. Nature Communications. Vol 9. Nro 4611. www / pdf

  • O. Kazumasa et al. 2018. Crystal structure of the red light-activated channelrhodopsin Chrimson. Nature Communications. Vol 9. Nro 3949. www / pdf

  • C. Krimm et al. 2018. Electrical properties, substrate specificity and optogenetic potential of the engineered light-driven sodium pump eKR2. Scientific Reports. Vol 8. Nro 9316. www / pdf

  • J. Wietek et al. 2017. Anion-conducting channelrhodopsins with tuned spectra and modified kinetics engineered for optogenetic manipulation of behavior. Scientific Reports. Vol 7. Nro 14957. www / pdf


  • T. Mondal et al. 2019. Ultrahigh efficiency μLEDs to counter Parkinson’s Disease. Poster. pdf


WP7 Dissemination and Exploitation

  • D7.1 Project website and logo (M3)

  • D7.2 Dissemination, exploitation and communication plan (M3, update M27)

WP8 Management

  • D8.1 Plan for Quality Assurance (M6)

  • D8.3 Final report (M50)

  • D7.4 Annual Meeting 1 (M12)